|
Report No. : |
315929 |
|
Report Date : |
02.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
ATUL LIMITED (w.e.f.31.07.1996) |
|
|
|
|
Formerly Known
As : |
ATUL PRODUCTS LIMITED |
|
|
|
|
Registered
Office : |
Atul House, G I Patel Marg, Ahmedabad – 380014, Gujarat |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2014 |
|
|
|
|
Date of
Incorporation : |
11.12.1975 |
|
|
|
|
Com. Reg. No.: |
04-002859 |
|
|
|
|
Capital Investment
/ Paid-up Capital : |
Rs.296.800 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
L99999GJ1975PLC002859 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
Not Available |
|
|
|
|
Legal Form : |
A Public Limited Liability Company. The Company’s Shares are Listed on
the Stock Exchanges. |
|
|
|
|
Line of Business
: |
Manufacturer of Dyestuff Chemicals, Drugs and
Pharmaceuticals. |
|
|
|
|
No. of Employees
: |
2761 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
A (63) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 27000000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Exist |
|
|
|
|
Comments : |
Subject is a well-established company having fine track record. The company’s products are well received in the market. Overall fundamentals are good. The rating also takes into consideration decent profit margins and good networth position of the company. Trade relations are fair. Business is active. Payment terms are reported to be regular and as per commitments. The company can be considered normal for business dealings at usual trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CARE Rating |
|
Rating |
Long term Bank facilities = AA+ |
|
Rating Explanation |
Having high degree of safety and carry very
low credit risk. |
|
Date |
November 25, 2014 |
|
Rating Agency Name |
CARE Rating |
|
Rating |
Short term Bank facilities = A1+ |
|
Rating Explanation |
Having strong degree of safety and carry
lowest credit risk. |
|
Date |
November 25, 2014 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION DENIED
MANAGEMENT NON
CO-OPERATIVE
CONTACT NO.:
91-22-39876000
LOCATIONS
|
Registered Office : |
Atul House, G I Patel Marg, Ahmedabad – 380014, Gujarat,
India |
|
Tel. No.: |
Not Available |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Head Office : |
Colours Division Post Atul, Valsad – 396020, |
|
Tel. No.: |
91-2632-233261/ 5 |
|
Fax No.: |
91-2632-233619/ 233375/ 233024/ 233619/ 233384 |
|
E-Mail : |
|
|
|
|
|
Mumbai Office : |
310 B, Veer Savarkar Marg, Adjacent to Prabhadevi Telephone Exchange, Opposite India United Mills, Prabhadevi, Dadar (West), Mumbai-400028, Maharashtra, India |
|
Tel. No.: |
91-22-39876000 |
|
Fax No.: |
91-22-24376061/ 24386065 |
|
E-Mail : |
|
|
|
|
|
Factory 1 : |
297, GIDC Industrial Estate, Ankleshwar - 393002, Gujarat, India |
|
|
|
|
Factory 2 : |
Atul, District Valsad - 396020, Gujarat, India |
|
|
|
|
Factory 3 : |
MIDC, Tarapur, Thane - 401506, Maharashtra, India |
|
|
|
|
Factory 4 : |
GIDC, Kharod, District Bharuch - 394115, Gujarat, India |
DIRECTORS
AS ON 31.03.2014
|
Name : |
Mr. S S Lalbhai |
|
Designation : |
Chairman and Managing Director |
|
|
|
|
Name : |
Mr. S A Lalbhai |
|
Designation : |
Managing Director |
|
|
|
|
Name : |
Mr. G S Patel |
|
Designation : |
Independent Director |
|
Date of Birth/ Age : |
16.11.1923 |
|
Brief Resume : |
Mr. G S Patel is
a Director of the Company since August 10, 1983. Mr. Patel was
the Chairman of Unit Trust of India. Previously he held directorships in 20
other companies in public and private sectors. Mr. Patel holds
BSc (Economics) degree from London School of Economics, Bar-at-Law degree
from Lincoln’s Inn and MA (Economics) and LLB degrees from the University of
Mumbai. |
|
|
|
|
Name : |
Dr. S S Baijal |
|
Designation : |
Independent Director |
|
Date of Birth/ Age : |
06.09.1929 |
|
Brief Resume : |
Dr. S S Baijal
is a Director of the Company since June 13, 1984. Dr. Baijal was a
Lecturer in Organic Chemistry, Lucknow University. He was a Whole-time
Director and CEO of Atic Industries Limited, Managing Director of IEL Limited
and Chairman and CEO of ICI companies in India. Dr. Baijal holds PhD degree in Chemistry from the University of
Allahabad. |
|
Directorship
in other companies : |
Public
Companies: · BMG Enterprises Limited · CAE Rossell India Limited · DCM Shriram Credit and Investments Limited · DCM Shriram Limited · Rossell Tea Limited Private
Companies: · Delhi Guest Houses Private Limited |
|
|
|
|
Name : |
Mr. B S Mehta |
|
Designation : |
Independent Director |
|
Date of Birth/ Age : |
19.09.1935 |
|
Brief Resume : |
Mr. B S Mehta is
a Director of the Company since April 16, 1992. Mr. Mehta is a
Practicing Chartered Accountant and is a Chief Mentor of B S Mehta and Co. He
is a past President of The Institute of Chartered Accountants of India. He
was involved in educational activities at the graduate and post graduate
levels in the University of Mumbai. Mr. Mehta holds
B Com (Hons) degree from the University of Mumbai and is a Fellow Member of
The Institute of Chartered Accountants of India. |
|
Directorship
in other companies : |
Public Companies: · Bharat Bijlee Limited · Ceat Limited · Century Enka Limited · Gillette India Limited · Housing Development Finance Corporation Limited · IL and FS Investment Managers Limited · J B Chemicals and Pharmaceuticals Limited · Jumbo World Holdings Limited (Body Incorporated outside India) · NSDL e-Governance Infrastructure Limited · Pidilite Industries Limited · Proctor and Gamble Hygiene and Health Care Limited · Sasken Communication Technologies Limited · SBI Capital Markets Limited · Sudarshan Chemical Industries Limited Private
Companies: · Uhde India Private Limited |
|
|
|
|
Name : |
Mr. H S Shah |
|
Designation : |
Independent Director |
|
Date of Birth/ Age : |
01.10.1934 |
|
Brief Resume : |
Mr. H S Shah is
a Director of the Company since October 21, 1992. Mr. Shah held several
senior and top positions in the Government of India and other academic |
research, commercial and social organisations. Mr. Shah holds
MA degree in Sociology from Gujarat University and has passed Indian
Administrative Service examination conducted by Union Public Service
Commission. Companies: Chairman,
Gujarat Industrial Investment Corporation Chairman and
Managing Director, Indian Petrochemicals Corporation Limited Vice Chairman,
GE Capital (India) Limited Academic |
Research: Chairman,
Darshak Itihas Nidhi Chairman,
Gujarat Ecology Society Chairman,
Gujarat Industrial Research and Development Agency Chairman,
National Institute of Design Founder
Chairman, Gujarat Institute of Desert Ecology Member, Board of
Governors of IIT, Mumbai President, Charutar
Arogya Mandal (Medical College and Hospital) Social: Chairman,
Gujarat Rural Institute for Socio Economic Reconstruction Vadodara Chairman,
Kachnar Trust Founder
President and Member, Heritage Trust Founder Trustee,
Indian Trust for Rural Heritage and Development Life Trustee,
BAIF Development Research Foundation Government: Chairman,
Gujarat Ecology Commission Joint Director,
Bureau of Public Enterprises, Government of India Joint Secretary
to the Prime Minister, Government of India Member, Central
Pollution Control Board Secretary, Posts
and Telegraph Board of India Others: Chairman, Vikram
A Sarabhai Community Science Centre Life Trustee and
Member, Gujarat Nature Conservation Society Trustee, Shram Mandir |
|
Directorship
in other companies : |
Public
Companies: · Sun Pharmaceutical Industries Limited · Supreme Petrochem Limited Private
Companies: · Flexican Bellows Private Limited |
|
|
|
|
Name : |
Mr. S M Datta |
|
Designation : |
Independent Director |
|
Date of Birth/ Age : |
01.07.1936 |
|
Brief Resume : |
Mr. S M Datta is
a Director of the Company since October 28, 2002. Mr. Datta is the
Chairman of Administrative Staff College of India. He is also associated with
various other renowned institutes. Mr. Datta was the
Chairman of Hindustan Unilever Limited as well as of all Unilever Group
companies in India and Nepal from 1990 to 1996. Mr. Datta is a
Chartered Engineer; Honorary Fellow - All India Management Association,
Fellow - Indian Institute of Chemical Engineers, Member - Society of Chemical
Industry (London) and Fellow - The Institution of Engineers (India). Mr. Datta holds
a post graduate degree in Science and Technology from the University of
Calcutta. |
|
Directorship
in other companies : |
Public
Companies: · Bhoruka Power Corporation Limited · Castrol India Limited - Chairman · Door Sabha Nigam Limited · ILandFS Investment Managers Limited - Chairman · Peerless Financial Products Distributors’ Limited - Chairman · Peerless General Finance and Investment Company Limited · Peerless Hotels Limited · Philips Electronics India Limited - Chairman · Rabo India Finance Limited · Speciality Restaurants Limited - Chairman · Transport Corporation of India Limited - Chairman · Zodiac Clothing Company Limited Private
Companies: · Chandras Chemical Enterprises Private Limited · SMD Management Consultants Private Limited |
|
|
|
|
Name : |
Mr. V S Rangan |
|
Designation : |
Independent Director |
|
Date of Birth/ Age : |
13.02.1960 |
|
Brief Resume : |
Mr. V S Rangan is
a Director of the Company since July 19, 2010. Mr. Rangan is an
Executive Director of Housing Development Finance Corporation Limited. Mr. Rangan is an
Associate of The Institute of Chartered Accountants of India and The
Institute of Cost and Works Accountants of India. |
|
Directorship
in other companies : |
Public
Companies: · Cholamandalam Investment and Finance Company Limited · HDFC Developers Limited · HDFC Holdings Limited · HDFC Investments Limited · HDFC Property Ventures Limited · HDFC Trustee Company Limited · HDFC Venture Capital Limited · Hindustan Oil Exploration Company Limited · Housing Development Finance Corporation Limited · TVS Credit Services Limited Private
Companies: · Credila Financial Services Private Limited · HDFC Education and Development Services Private Limited · IVF Advisors Private Limited · Ruralshores Business Services Private Limited |
|
|
|
|
Name : |
Mr. R A Shah |
|
Designation : |
Independent Director |
|
|
|
|
Name : |
Mr. B N Mohanan |
|
Designation : |
Whole-time Director |
|
Date of Birth/ Age : |
26.05.1950 |
|
Brief Resume : |
Mr. B N Mohanan
is a Whole-time Director of the Company since January 01, 2009. He joined the
Company in 1992. Mr. Mohanan has over
4 decades of professional experience in various capacities. Currently, he is
the President, Infrastructure Unit and also the Occupier. His
responsibilities include safety, health, environment, utilities and
engineering procurement. Mr. Mohanan holds BSc (Engg Hon) degree from the University of
Calicut. |
|
Directorship
in other companies : |
Public
Companies: · Aasthan Dates Limited - Chairman · Atul Biospace Limited - Chairman and Managing Director · Atul Clean Energy Limited - Chairman · Atul Rajasthan Date Palms Limited - Managing Director · Atul Seeds Limited · Biyaban Agri Limited - Chairman · Raja Dates Limited - Chairman ·
DPD Limited |
|
|
|
|
Name : |
Mr. S Nammalvar |
|
Designation : |
Whole-time Director |
|
Date of Birth/ Age : |
27.05.1954 |
|
Brief Resume : |
Mr. S Nammalvar
joined the Company in 2011 as President, Technology Unit. His
responsibilities include heading technology and manufacturing functions of
the Company. Mr. Nammalvar
has over 34 years of experience in various functions and has held leadership
positions for over 20 years in companies belonging to Petrochemical,
Pharmaceutical and Polymer industries in India and abroad. Mr. Nammalvar
holds ME degree in Chemical Engineering from Annamalai University and Post
Graduate Diploma in Business Management from the University of Pune. |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 31.12.2014
|
Category of Shareholder |
Total
No. of Shares |
As a % |
|
(A) Shareholding
of Promoter and Promoter Group |
|
|
|
|
|
|
|
|
854316 |
2.88 |
|
|
14177219 |
47.80 |
|
|
15031535 |
50.68 |
|
|
|
|
|
Total
shareholding of Promoter and Promoter Group (A) |
15031535 |
50.68 |
|
|
|
|
|
(B) Public
Shareholding |
|
|
|
|
|
|
|
|
3036942 |
10.24 |
|
|
63770 |
0.21 |
|
|
336 |
0.00 |
|
|
498767 |
1.68 |
|
|
1701389 |
5.74 |
|
|
872 |
0.00 |
|
|
872 |
0.00 |
|
|
5302076 |
17.88 |
|
|
|
|
|
|
1475737 |
4.98 |
|
|
|
|
|
|
4783173 |
16.13 |
|
|
2815872 |
9.49 |
|
|
253340 |
0.85 |
|
|
145542 |
0.49 |
|
|
88048 |
0.30 |
|
|
19750 |
0.07 |
|
|
9328122 |
31.45 |
|
Total Public
shareholding (B) |
14630198 |
49.32 |
|
|
|
|
|
Total (A)+(B) |
29661733 |
100.00 |
|
|
|
|
|
(C) Shares held
by Custodians and against which Depository Receipts have been issued |
|
|
|
|
0 |
0.00 |
|
|
0 |
0.00 |
|
|
0 |
0.00 |
|
|
|
|
|
Total
(A)+(B)+(C) |
29661733 |
100.00 |

BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Dyestuff Chemicals, Drugs and
Pharmaceuticals. |
||||||||
|
|
|
||||||||
|
Products : |
|
||||||||
|
|
|
||||||||
|
Brand Names : |
-- |
||||||||
|
|
|
||||||||
|
Agencies Held : |
-- |
||||||||
|
|
|
||||||||
|
Exports : |
Not Available |
||||||||
|
|
|
||||||||
|
Imports : |
Not Available |
||||||||
|
|
|
||||||||
|
Terms : |
Not Available |
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
No. of Employees : |
2761 (Approximately) |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Bankers : |
· Axis Bank · Bank of Baroda · Bank of India · Export Import Bank of India ·
State Bank of India |
||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
|
Facilities : |
|
||||||||||||||||||||||||||||||
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Dalal and Shah Chartered Accountants |
|
|
|
|
Cost Auditors |
|
|
Name : |
R. Nanabhoy and Company Cost Accountants |
|
|
|
|
Subsidiary Companies : |
·
Aasthan Dates Limited ·
Subsidiary companies ·
Ameer Trading Corporation Limited ·
Atul Bioscience Limited ·
Atul Biospace Limited ·
Atul Brasil Quimicos Ltda ·
Atul China Limited ·
Atul Deutschland GmbH ·
Atul Europe Limited ·
Atul Infotech Private Limited ·
Atul Rajasthan Date Palms Limited ·
Atul USA Inc ·
Biyaban Agri Limited ·
DPD Limited ·
Raja Dates Limited |
|
|
|
|
Joint Venture
Company : |
Rudolf Atul Chemicals Limited |
|
|
|
|
Associate Companies
: |
·
Amal Limited ·
Anchor Adhesives Private Limited ·
Atul Crop Care Limited ·
LAPOX Polymers Limited ·
M. Dohmen S.A. ·
Atul Elkay Polymers Limited |
|
|
|
|
Organisations over
which significant influence exercised : |
· Welfare funds · Atul Club · Atul Kelavani Mandal · Atul Rural Development Fund ·
Atul Vidyalaya |
CAPITAL STRUCTURE
AS ON 31.03.2014
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
80000000 |
Equity Shares |
Rs. 10/-
each |
Rs. 800.000
Million |
|
8000000 |
Cumulative Redeemable Preference Shares |
Rs. 100/- each |
Rs. 800.000 Million |
|
|
|
|
|
|
|
Total |
|
Rs. 1600.000 Million |
Issued Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
29691780 |
Equity Shares |
Rs. 10/- each |
Rs. 296.900 Million |
|
|
|
|
|
Subscribed and Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
29661733 |
Equity Shares |
Rs. 10/- each |
Rs. 296.600 Million |
|
29991 |
Add: Forfeited Shares (amount paid up) |
|
Rs. 0.200 Million |
|
|
|
|
|
|
|
Total |
|
Rs. 296.800 Million |
a)
Rights,
Preferences and restrictions
The Company has
two classes of Shares referred to as Equity Shares having a par value of Rs.10
and Cumulative Redeemable Preference Shares having a par value of Rs.100.
i) Equity Shares:
In the event of
liquidation of the Company, the holders of Equity Shares will be entitled to
receive any of the remaining assets of the Company, after distribution of all
preferential amounts and Preference Shares.
The distribution
will be in proportion to the number of Equity Shares held by the Shareholders.
Each holder of Equity Shares is entitled to one vote per share.
ii) Preference
Shares:
The Company has
Preference Shares having a par value of Rs.100 per share. Each Shareholder is
eligible for dividend depending upon their coupon rates. The Preference
Shareholder is entitled to one vote per share only on resolutions placed before
the Company which directly affect the rights attached to the Preference Shares.
iii) Dividend:
The Company
declares and pays dividend in Indian rupees. The dividend proposed by the Board
of Directors is subject to the approval of the Shareholders in the ensuing
Annual General Meeting.
b)
Shares reserved
for issue at a later date
56 Equity Shares
are held in abeyance due to disputes at the time of earlier rights issues.
c)
Details of Shareholders holding more than 5% of Equity
Shares:
|
Name of the Shareholders |
As at March 31, 2014 |
|
|
|
Holding % |
No of shares |
|
Aeon Investments Private Limited* |
22.70 |
6725501 |
|
Aura Securities Private Limited |
5.44 |
1614045 |
|
Aeon
Investments Private Limited |
3.50 |
1039383 |
* During the year
certain Promoter group companies were merged. However, there is no change in
shareholding of the Promoters due to this merger.
FINANCIAL DATA
[all figures are
in Rupees Million]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
296.800 |
296.800 |
296.800 |
|
(b) Reserves & Surplus |
9119.100 |
7264.100 |
6122.500 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending
allotment |
0.000 |
0.000 |
0.000 |
|
Total Shareholders’
Funds (1) + (2) |
9415.900 |
7560.900 |
6419.300 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
1133.600 |
1544.300 |
1449.000 |
|
(b) Deferred tax liabilities (Net) |
353.900 |
271.600 |
223.100 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term
provisions |
51.900 |
50.400 |
33.300 |
|
Total Non-current
Liabilities (3) |
1539.400 |
1866.300 |
1705.400 |
|
|
|
|
|
|
(4)
Current Liabilities |
|
|
|
|
(a) Short
term borrowings |
1842.700 |
1604.500 |
1935.700 |
|
(b) Trade
payables |
3168.700 |
2753.200 |
2778.400 |
|
(c) Other
current liabilities |
1337.300 |
1129.600 |
1049.700 |
|
(d) Short-term
provisions |
432.100 |
360.400 |
511.400 |
|
Total Current
Liabilities (4) |
6780.800 |
5847.700 |
6275.200 |
|
|
|
|
|
|
TOTAL |
17736.100 |
15274.900 |
14399.900 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1)
Non-current assets |
|
|
|
|
(a) Fixed
Assets |
|
|
|
|
(i)
Tangible assets |
5196.000 |
4804.500 |
4175.500 |
|
(ii)
Intangible Assets |
0.000 |
0.000 |
2.200 |
|
(iii)
Capital work-in-progress |
529.800 |
459.300 |
559.400 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
1364.700 |
1285.600 |
1250.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
290.600 |
315.800 |
281.100 |
|
(e) Other
Non-current assets |
643.100 |
436.300 |
347.400 |
|
Total Non-Current
Assets |
8024.200 |
7301.500 |
6615.600 |
|
|
|
|
|
|
(2)
Current assets |
|
|
|
|
(a)
Current investments |
0.000 |
0.000 |
0.000 |
|
(b)
Inventories |
3757.500 |
3075.300 |
2945.700 |
|
(c) Trade
receivables |
4472.600 |
3616.000 |
3682.200 |
|
(d) Cash
and cash equivalents |
88.000 |
78.400 |
115.200 |
|
(e)
Short-term loans and advances |
1025.400 |
1034.600 |
869.400 |
|
(f) Other
current assets |
368.400 |
169.100 |
171.800 |
|
Total
Current Assets |
9711.900 |
7973.400 |
7784.300 |
|
|
|
|
|
|
TOTAL |
17736.100 |
15274.900 |
14399.900 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
||
|
|
SALES |
|
|
|
||
|
|
|
Revenue from operations (net) |
23654.500 |
20014.800 |
17776.800 |
|
|
|
|
Other Income |
396.200 |
204.600 |
143.800 |
|
|
|
|
TOTAL (A) |
24050.700 |
20219.400 |
17920.600 |
|
|
|
|
|
|
|
||
|
Less |
EXPENSES |
|
|
|
||
|
|
|
Cost of Materials Consumed |
13246.000 |
11270.500 |
10551.300 |
|
|
|
|
Purchases of Stock-in-Trade |
236.900 |
163.600 |
200.100 |
|
|
|
|
Changes in inventories of finished goods, work-in-progress
and Stock-in-Trade |
(664.700) |
(0.600) |
(153.300) |
|
|
|
|
Employees benefits expense |
1397.900 |
1276.000 |
1172.000 |
|
|
|
|
Other expenses |
6007.100 |
4832.700 |
4002.600 |
|
|
|
|
Exceptional Items |
0.000 |
(53.800) |
(65.100) |
|
|
|
|
Exchange rate difference [net] |
0.000 |
0.000 |
120.700 |
|
|
|
|
TOTAL (B) |
20223.200 |
17488.400 |
15828.300 |
|
|
|
|
|
|
|
||
|
|
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
3827.500 |
2731.000 |
2092.300 |
||
|
|
|
|
|
|
||
|
Less |
FINANCIAL
EXPENSES (D) |
314.300 |
316.200 |
431.000 |
||
|
|
|
|
|
|
||
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
3513.200 |
2414.800 |
1661.300 |
||
|
|
|
|
|
|
||
|
Less |
DEPRECIATION/
AMORTISATION (F) |
542.300 |
490.600 |
436.500 |
||
|
|
|
|
|
|
||
|
|
PROFIT BEFORE
TAX (E-F) (G) |
2970.900 |
1924.200 |
1224.800 |
||
|
|
|
|
|
|
||
|
Less |
TAX (H) |
843.000 |
569.000 |
343.700 |
||
|
|
|
|
|
|
||
|
|
PROFIT AFTER TAX
(G-H) (I) |
2127.900 |
1355.200 |
881.100 |
||
|
|
|
|
|
|
||
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
||
|
|
|
FOB Value of Exports |
10452.600 |
9290.100 |
7775.500 |
|
|
|
|
|
|
|
||
|
|
IMPORTS |
|
|
|
||
|
|
|
Raw Materials |
3871.600 |
3139.100 |
3095.400 |
|
|
|
|
Trading finished goods |
284.600 |
109.800 |
110.300 |
|
|
|
|
Capital Goods |
76.800 |
44.500 |
54.700 |
|
|
|
TOTAL IMPORTS |
4233.000 |
3293.400 |
3260.400 |
||
|
|
|
|
|
|
||
|
|
Earnings Per
Share (Rs.) |
71.74 |
45.69 |
29.70 |
||
QUARTERLY RESULTS
|
PARTICULARS |
30.06.2014 |
30.09.2014 |
|
Type |
1st
Quarter |
2nd
Quarter |
|
Net Sales |
6470.800 |
6624.100 |
|
Total Expenditure |
5432.500 |
5654.400 |
|
PBIDT (Excl OI) |
1038.300 |
969.700 |
|
Other Income |
15.200 |
85.600 |
|
Operating Profit |
1053.500 |
1055.300 |
|
Interest |
61.700 |
57.300 |
|
Exceptional Items |
0.000 |
0.000 |
|
PBDT |
991.800 |
998.000 |
|
Depreciation |
135.600 |
136.700 |
|
Profit Before Tax |
856.200 |
861.300 |
|
Tax |
258.400 |
270.600 |
|
Provisions and contingencies |
0.000 |
0.000 |
|
Profit After Tax |
597.800 |
590.700 |
|
Extraordinary Items |
0.000 |
0.000 |
|
Prior Period Expenses |
0.000 |
0.000 |
|
Other Adjustments |
0.000 |
0.000 |
|
Net Profit |
597.800 |
590.700 |
KEY RATIOS
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Net Profit Margin (PAT / Sales) |
(%) |
9.00 |
6.77 |
4.96 |
|
|
|
|
|
|
|
Operating Profit Margin (PBIDT/Sales) |
(%) |
16.18 |
13.64 |
11.77 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
18.75 |
14.22 |
9.73 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.32 |
0.25 |
0.19 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.32 |
0.42 |
0.53 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.43 |
1.36 |
1.24 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs. In Million) |
(Rs. In Million) |
(Rs. In Million) |
|
Share Capital |
296.800 |
296.800 |
296.800 |
|
Reserves & Surplus |
6122.500 |
7264.100 |
9119.100 |
|
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Net worth |
6419.300 |
7560.900 |
9415.900 |
|
|
|
|
|
|
long-term borrowings |
1449.000 |
1544.300 |
1133.600 |
|
Short term borrowings |
1935.700 |
1604.500 |
1842.700 |
|
Total borrowings |
3384.700 |
3148.800 |
2976.300 |
|
Debt/Equity ratio |
0.527 |
0.416 |
0.316 |

YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs. In Million) |
(Rs. In Million) |
(Rs. In Million) |
|
Sales |
17776.800 |
20014.800 |
23654.500 |
|
|
|
12.589 |
18.185 |

NET PROFIT MARGIN
|
Net Profit Margin |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs. In Million) |
(Rs. In Million) |
(Rs. In Million) |
|
Sales |
17776.800 |
20014.800 |
23654.500 |
|
Profit |
881.100 |
1355.200 |
2127.900 |
|
|
4.96% |
6.77% |
9.00% |

LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
-- |
|
22] |
Litigations that the firm
/ promoter involved in |
Yes |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
-- |
|
26] |
Buyer visit details |
-- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of Proprietor/Partner/Director,
if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
Yes |
LITIGATION DETAILS
|
HIGH COURT OF
GUJARAT CIVIL
APPLICATION (FOR ORDERS) No. 11985 of 2012 In FIRST APPEAL / 1951 /
2012 (PENDING) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Status: PENDING ( Converted from :
CAST/12157/2012 ) CCIN
No: 001003201211985 Last Listing Date: 16/01/2013 Coram: - HONOURABLE THE CHIEF
JUSTICE MR. BHASKAR BHATTACHARYA HONOURABLE
MR.JUSTICE J.B.PARDIWALA |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
S.NO. |
Name of the
Petitioner |
Advocate On
Record |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1 |
JENSON NICHOLSAN INDIA LTD |
MR ADIL R MIRZA for: Petitioner(s) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
S.NO. |
Name of the
Respondant |
Advocate On
Record |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1 |
ATUL LIMITED |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Presented On : 16/10/2012 Registered On : 17/10/2012 Bench Category : DIVISION BENCH District : VALSAD Case Originated From: THROUGH
HIS/HER/THEIR ADVOCATE Listed : 4
times Stage Name : NOTICE &
ADJOURNED MATTERS
Office Details |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
S. No |
Filing Date |
Document Name |
Advocate Name |
Court Fee on
Document |
Document Details |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1 |
16/10/2012 |
APPLICATION |
MR ADIL R MIRZA ADVOCATE |
20 |
MR ADIL R
MIRZA:1-2 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Linked
Matters
Court
Proceedings
Available Orders
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INDEX OF
CHARGES
|
S.NO. |
CHARGE ID |
DATE OF CHARGE
CREATION/MODIFICATION |
CHARGE AMOUNT
SECURED |
CHARGE HOLDER |
ADDRESS |
SERVICE REQUEST
NUMBER (SRN) |
|
1 |
10409602 |
16/03/2013 * |
527,700,000.00 |
STATE BANK OF INDIA |
MID CORPORATE GROUP, COMMERCIAL BR., PARAMSIDDHI, |
B71065403 |
|
2 |
10294426 |
30/07/2011 * |
562,500,000.00 |
INTERNATIONAL FINANCE CORPORATION |
MARUTI SUZUKI BUILDING, 3RD FLOOR, PLOT NO. 1, NE |
B18004713 |
|
3 |
10273656 |
31/05/2012 * |
276,000,000.00 |
BARCLAYS BANK PLC |
FIRST FLOOR, EROS CORPORATE TOWER, NEHRU PLACE, N |
B40839474 |
|
4 |
10090594 |
25/03/2008 * |
781,200,000.00 |
INTERNATIONAL FINANCE CORPORATION |
GODREJ BHAVAN, 3RD FLOOR, MURZBAN ROAD, FORT, MUM |
A34455931 |
|
5 |
80026120 |
03/08/2013 * |
4,300,000,000.00 |
STATE BANK OF INDIA(LEAD BANK OF CONSORTIUM MEMBER |
PARAMSIDDHI, COMMERCIAL BRANCH, OPP V S HOSPITAL, |
B82224783 |
|
6 |
80026296 |
08/03/1999 |
150,000,000.00 |
EXPORT IMPORT BANK OF INDIA |
CENTRE ONE, WORLD TRADE CENTRE, CUFFE PARADE, MUM |
- |
* Date of charge modification
NOTE
The registered office of the company has been
shifted from Ashoka Chambers, Rasala Marg, Eillsbridge, Ahmedabad – 380006, Gujarat,
India to the present address.
UNSECURED LOANS
|
PARTICULARS |
31.03.2014 Rs.
In Million |
31.03.2013 Rs.
in Million |
|
LONG TERM BORROWINGS |
|
|
|
Rupee Term Loans
from Banks |
1.000 |
0.200 |
|
SHORT TERM BORROWINGS |
|
|
|
Loans from Banks
Including Foreign Banks |
550.000 |
0.000 |
|
Buyer’s credit
arrangement |
0.000 |
93.600 |
|
|
|
|
|
Total |
551.000 |
93.800 |
PERFORMANCE
Sales
increased by 17% from Rs.19640.000 Million to Rs.2,3070.000 Million aided by both
higher volumes (8%) and prices (9%). Sales in India increased by 22% from Rs.
9860.000 Million to Rs.11990.000 Million. Sales outside of India increased by
13% from Rs.9780.000 Million to Rs.11080.000 Million. Revenue from operations
increased by 18% from Rs.20010.000 Million to Rs.23650.000 Million. PBT for the
year includes about Rs.200.000 Million of one-time special dividend income
received; including such special income, the earnings per share increased from
Rs.456.900 to Rs.717.400 Million. While the operating profit before working
capital changes increased by 38% from Rs.2600.000 Million to Rs.3600.000
Million, the net cash flow from operating activities declined by 16% from
Rs.1670.000 Million to Rs.1410.000 Million mainly on account of the growth in
working capital consequent to the higher level of sales achieved.
Both
the Segments of the Company, namely, Life Science Chemicals Segment (LSC) and
Performance and Other Chemicals Segment (POC) showed improvement in performance.
The sales of LSC increased by 6% from Rs.6990.000 Million to Rs.7380.000
Million, aided by higher sales of Crop Protection and Pharmaceuticals and
Intermediates and its EBIT increased by 8% from Rs.1390.000 Million to
Rs.1500.000 Million. The sales of POC increased by 24% from to Rs.12650.000
Million Rs.15690.000 Million, supported by growth in Colors and Polymers and
its EBIT increased from Rs.900.000 Million to Rs.1730.000 Million.
The
Company reduced its borrowings (including current maturities on long-term
borrowings) by 1% from Rs.3550.000 Million to
Rs.3510.000 Million despite the growth in working capital to
support higher sales and payments towards capital expenditure of about
Rs.1000.000 Million.
The
Company improved its credit rating from ‘AA-‘ (double A minus) to ‘AA’ (double
A) for its long-term borrowings, awarded by CARE. Its rating for short-term
borrowings and commercial paper remained at A1+, the highest possible, awarded
by CARE.
The
Company is in the process of implementing 33 projects with a total outlay of
about Rs.4800.000 Million; these projects are expected to be commissioned in
during 2014-15 and 2015-16. It completed 14 projects related to environment
protection during 2013-14 and is expected to complete 8 more projects by way of
reduction in and treatment of pollutants.
MANAGEMENT
DISCUSSION AND ANALYSIS
BUSINESS-WISE
PERFORMANCE
CROP PROTECTION
Crop Protection Business mainly comprises Fungicides, Herbicides and
Insecticides. The products are used by customers belonging to Agriculture
industry for the protection of crops. The Business comprises about 15 products
and 46 formulations.
During 2013-14, sales increased by 12% from Rs. 3850.000 Million to Rs.
4330.000 Million. Sales in India increased by 40% from Rs. 1410.000 Million to
Rs. 1970.000 Million; bulk sales in India increased by 38% from Rs. 680.000
Million to Rs. 940.000 Million whereas brand sales which are currently only in
India increased by 41% from Rs. 730.000 Million to Rs. 1030.000 Million. Sales outside
of India decreased by 3% from Rs. 2440.000 Million to Rs. 2360.000 Million and
formed 55% of the total. Growth on account of volume was 10%. Sales from new
products and formulations were Rs. 70.000 Million. The Company completed 2
projects and undertook 3 projects for implementation.
World market for crop protection chemicals is estimated at US$ 54 bn and
is growing at about 3%. Indian market for such chemicals is estimated at US$
1.5 bn and is growing at about 7%. There are about 60 major companies which
dominate the world marketplace, and there are about 13 companies in India
having sales of more than US$ 100 mn.
The main user industry, namely, Agriculture, is growing well because of
increasing population on the one hand and improving standard of living on the
other. The Company will participate in this growth by i) building a strong
sales and marketing organisation and broadening and deepening its presence in
other countries, particularly in Africa and South America, ii) promoting its
brands, iii) increasing its manufacturing and working capital efficiencies, iv)
generating and adding capacities and v) introducing new products and
formulations.
Floods or famines will adversely affect the demand. Registration costs
are high in certain countries. Fluctuations in foreign exchange may impact
sales realizations. Given that some of these chemicals can be toxic, it is
essential to take utmost care in their manufacture and use.
PHARMACEUTICALS
Pharmaceuticals and Intermediates Business mainly comprises API
intermediates and a few APIs. The products are used by customers belonging to
Pharmaceutical industry, under five broad therapeutic categories, namely,
anti-depressant, antidiabetic, anti-infective, anti-retroviral and
cardiovascular. The Business comprises about 38 products.
During 2013-14, sales decreased by 3% from Rs. 3140.000 Million to Rs.
3060.000 Million. Sales in India increased by 1% from Rs. 1710.000 Million to
Rs. 1720.000 Million. Sales outside of India decreased by 6% Rs. 1430.000
Million to Rs. 1340.000 Million and formed 44% of the total. Degrowth on
account of volume was 7%. Sales from new products were Rs. 70.000 Million. The
Company completed 8 projects and undertook 3 projects for implementation. Atul
Bioscience Limited, a 100% subsidiary company, focussed on production of
advanced API intermediates, sales of which increased by 30% from Rs. 270.000
Million to Rs. 350.000 Million, primarily because of volume; and it completed
capacity expansion in both of its plants.
World market for pharmaceuticals is estimated at US$ 820 bn (comprising
US$ 700 bn prescription drugs and US$ 120 bn generic drugs) and is growing at
about 5%. Indian pharmaceuticals market is estimated at US$ 22 bn (including
sales out of India) and is growing at about 10%. There are about 20 major
companies which dominate the world marketplace in prescription drugs space with
share of about 65% and about 8 companies in generic drugs space with share of
about 70%.
The main user industry, namely, Pharmaceutical, is growing well because
of increasing awareness about diseases and health. The Company along with Atul
Bioscience will participate in this growth by i) widening its market reach, ii)
increasing its manufacturing efficiencies, iii) generating and adding
capacities and iv) introducing new products. It will also form long-term
alliances with other companies.
Prices of many products come down significantly in a short time.
Fluctuations in foreign exchange may impact sales realisations.
AROMATICS
Aromatics Business mainly comprises p-Cresol and its downstream
products. The products are mainly used by customers belonging to Flavour and
Fragrance and Personal Care industries. The Business comprises about 29 products.
During 2013-14, sales increased by 6% from Rs. 3880.000 Million to Rs.
4100.000 Million. Sales in India decreased by 10% from Rs. 1130.000 Million to
Rs. 1020.000 Million. Sales outside of India increased by 12% from Rs. 2750.000
Million to Rs. 3080.000 Million and formed 75% of the total. Growth on account
of volume was 3%. Sales from new products were Rs. 60.000 Million. The Company
completed 6 projects and undertook 4 projects for implementation. World market
of p-Cresol is estimated at 55,000 mt and is growing at about 3%. Though
earlier the product used to be manufactured in the UK and the USA, China and
India are now the major suppliers of the product. World market of flavour and
fragrance chemicals is estimated at US$ 23 bn and is growing at about 5%.
The main user industries, namely, Flavour and Fragrance and Personal
Care, are growing well because of increasing population on the one hand and
improving standard of living on the other. The Company will participate in this
growth by i) broadening its market reach, ii) increasing its manufacturing
efficiencies, iii) adding capacities and iv) introducing new products.
The prices of key raw materials which are derived from crude oil
fluctuate almost monthly whereas the customers in the user industries expect
the prices of the finished products to remain firm for a quarter or even more;
on such occasions, it is possible to get affected adversely. Fluctuations in
foreign exchange may impact sales realisations.
BULK CHEMICALS AND
INTERMEDIATES
Bulk Chemicals and Intermediates Business mainly comprises Sodium
Hydroxide, Chlorine, Sulphuric Acid, Oleum, Sulphur Trioxide, Chlorosulphonic
Acid and Resorcinol. Barring Chlorosulphonic Acid and Resorcinol, the rest of
the products are used for captive consumption. Resorcinol is mainly used by
customers belonging to Tyre industry. The Business comprises about 26 products.
During 2013-14, (external) sales increased by 29% from Rs. 770.000
Million to Rs. 990.000 Million. Sales in India increased by 37% from Rs.
600.000 Million to Rs. 820.000 Million. Sales outside of India remained
constant at Rs. 170.000 Million and formed 17% of the total. Growth on account
of volume was 16%. Sales from new products were Rs. 190.000 Million. The
Company completed 1 project and undertook 2 projects for implementation.
World market for bulk chemicals is growing at about 0.5% and Indian
market is growing at about 2%. World market for Resorcinol is estimated at US$ 300
mn and is growing at about 3%; Indian market for the product is estimated at
US$ 15 mn and is growing at about 5%.
The captive consumption of bulk chemicals is expected to grow as the
Company expands manufacturing capacities of its various products. Tyre industry
is expected to grow further because of increasing population on the one hand
and improving standard of living on the other. The Company will participate in
this growth by i) widening its market reach, ii) increasing its manufacturing
efficiencies, iii) modernising its bulk chemicals plant, iv) adding capacities
and v) introducing new and downstream products.
The demand and prices of bulk chemicals are cyclical in nature.
Fluctuations in foreign exchange may impact sales realisations.
COLORS
Colors Business mainly comprises dyes for natural fibres such as Vat,
Sulphur Black and Reactive and in a small way high performance pigments. The
products are used by customers belonging to Textile and Paint and Coatings
industries. The Business comprises about 550 products. Rudolf Atul Chemicals
Limited, a JV company formed in 2011-12, provides a complete range of textile
chemicals in Indian market.
During 2013-14, sales increased by 29% from Rs. 3300.000 Million to Rs.
4260.000 Million. Sales in India increased by 24% from Rs. 1870.000 Million to
Rs. 2310.000 Million. Sales outside of India increased by 36% from Rs. 1430.000
Million to Rs. 1950.000 Million and formed 46% of the total. Increase on
account of volume was 6%. Sales from new products were Rs. 300.000 Million. The
Company completed 5 projects and undertook 4 projects for implementation. It
sold off its shareholding in M. Dohmen S.A., a JV company; the transaction was
however completed on April 03, 2014. Rudolf Atul Chemicals increased sales by
51% from Rs. 210.000 Million to Rs. 310.000 Million, mainly because of volume
growth.
World market for dyes and textile chemicals is estimated at US$ 12 bn
and is growing at about 2% and Indian market is estimated at US$ 800 mn and is
growing at about 3%. China is the largest manufacturer of dyes followed by
India. World market for high performance pigments is estimated at US$ 3.5 bn
and is growing at about 4%.
The main user industry, namely, Textile, is showing signs of recovery in
India and abroad. Automobile industry is growing well. The Company along with
Rudolf Atul Chemicals will participate in this growth by i) broadening its
market reach, ii) increasing its manufacturing and working capital efficiencies
and iii) introducing new dyes, pigments and textile chemicals.
Fluctuations in foreign exchange may impact sales realisations.
Treatment costs are expected to remain high given that the manufacture of dyes
generates significant pollutants.
POLYMERS
Polymers Business mainly comprises Epoxy Resins and Hardeners and
formulations thereof, other components such as air release agents, reactive
diluents, rheological modifiers, wetting agents, etc and Sulphones. These
products are used by Automobile, Construction, Defence, Electrical and
Electronics, Footwear, Handicraft, Marine, Paint and Coatings, Paper and Wind
Energy industries. The Business comprises about 64 products and 275
formulations.
During 2013-14, sales increased by 35% from Rs. 4680.000 Million to Rs.
6330.000 Million. Sales in India increased by 33% from Rs. 3120.000 Million to
Rs. 4150.000 Million. Brand sales which is currently only in India increased by
18% from Rs. 720.000 Million from to Rs. 850.000 Million. Sales outside of
India increased by 40% from Rs. 1560.000 Million to Rs. 2180.000 Million and
formed 34% of the total. Increase on account of volume was 24%. Sales from new
products were Rs. 120.000 Million. The Company completed 4 projects and
undertook 5 projects for implementation. Though already incorporated, Atul
Elkay Polymers Limited, a JV company, is still assessing the demand potential
for stone care chemicals in India.
World market for Epoxy Resins and Hardeners is estimated at US$ 6.2 bn
and is growing at about 2% and Indian market is estimated at US$ 225 mn and is
growing at about 5%. There are about 7 major companies which dominate the world
marketplace. The two key raw materials, namely Bisphenol-A and Epichlorohydrin,
are imported into India. World market for Sulphones is estimated at US$ 300 mn
and is growing at about 4%.
The user industries, Construction, Defence, Electrical and Electronics
and Paint and Coatings, are growing well, particularly in India. The Company
will participate in this growth by i) widening its market reach, ii) increasing
its manufacturing and working capital efficiencies, iii) generating and adding
new capacities of Epoxy Resins and Hardeners and iv) introducing new products
and formulations.
Cheaper imports of Epoxy Resins and Hardeners will keep the contribution
margins under pressure. Since the two main raw materials are imported,
fluctuations in foreign exchange may impact margins.
CONTINGENT
LIABILITIES:
|
Particulars |
31.03.2014 (Rs.
In Million) |
31.03.2013 (Rs.
In Million) |
|
Claims against the Company not
acknowledged as debts in respects of: |
|
|
|
(a) Excise |
72.100 |
58.400 |
|
(b) Income tax |
281.000 |
350.300 |
|
(c) Sales tax |
6.700 |
0.000 |
|
(d) Customs |
27.800 |
27.800 |
|
(e) Water charges |
770.300 |
719.200 |
|
(f) Others |
146.400 |
135.400 |
|
|
|
|
|
Total |
1304.300 |
1291.100 |
|
NOTE: Future cash outflows in respect
of (a) to (f) above are determinable on receipt of judgements | decisions pending
with various forums | authorities |
||
FIXED ASSETS:
· Land – Freehold
· Buildings
· Roads
· Plant and Equipment
· Railway Siding
· Office Equipment and Furniture
· Vehicles
· Computer software
STANDALONE
UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31.12.2014
(RS. IN MILLION)
|
PARTICULARS |
Quarter Ended |
Nine Months
Ended |
|
|
|
31.12.2014 [Unaudited] |
30.09.2014 [Unaudited] |
31.12.2014 [Unaudited] |
|
Income from Operations |
|
|
|
|
Net Sales/Income from Operations |
6171.800 |
6512.400 |
19046.100 |
|
Other Operating Income |
99.400 |
111.700 |
320.000 |
|
Total Income from
operations (net) |
6271.200 |
6624.100 |
19366.100 |
|
|
|
|
|
|
Expenses |
|
|
|
|
(a) Cost of material consumed |
3247.700 |
3618.100 |
10406.800 |
|
(b) Purchase of stock in trade |
61.400 |
84.100 |
223.800 |
|
(c) Changes in inventories of finished goods, work in
progress and stock in trade |
27.000 |
(52.500) |
(85.300) |
|
(d) Power, fuel and water |
734.600 |
751.400 |
2209.600 |
|
(e) Employee benefit expenses |
387.700 |
383.600 |
1172.000 |
|
(f) Depreciation and amortization expenses |
138.500 |
136.700 |
410.800 |
|
(g) Other Expenses |
870.700 |
869.700 |
2489.100 |
|
Total Expenses |
5467.600 |
5791.100 |
16826.800 |
|
Profit from Operations
before Other Income, Finance costs |
803.600 |
833.000 |
2539.300 |
|
Other Income |
38.600 |
85.600 |
139.400 |
|
Profit/ Loss from
Ordinary Activities before Finance costs |
842.200 |
918.600 |
2678.700 |
|
Finance costs |
62.500 |
57.300 |
181.500 |
|
Profit/ Loss from Ordinary Activities
before tax |
779.700 |
861.300 |
2497.200 |
|
Tax Expenses |
|
|
|
|
- Current Tax |
215.00 |
235.000 |
698.700 |
|
- Deferred
Tax |
27.600 |
35.600 |
72.900 |
|
Net Profit/ Loss from Ordinary Activities
after tax |
537.100 |
590.700 |
1725.600 |
|
Paid- up
Equity Share Capital (Face value of the share – Rs. 10) |
296.600 |
296.600 |
|
|
Reserves excluding
revaluation reserves as per balance sheet of Previous Accounting Year |
-- |
-- |
-- |
|
Earnings Per
Share |
|
|
|
|
Basic and
Diluted |
18.11 |
19.92 |
58.18 |
|
|
|
|
|
|
PARTICULARS OF SHAREHOLDING |
|
|
|
|
1. Public
shareholding |
|
|
|
|
Number of
Shares |
14630198 |
14639571 |
14630198 |
|
Percentage of Shareholding |
49.32% |
49.36% |
49.32% |
|
2. Promoters
and promoter group shareholding |
|
|
|
|
a)
Pledged/Encumbered |
|
|
|
|
- Number of Shares |
430000 |
430000 |
430000 |
|
- Percentage of Shares (as a % of the Total Shareholding
of promoter and promoter group) |
2.86% |
2.86% |
2.86% |
|
- Percentage of Shares (as a % of the Total Share Capital
of the Company) |
1.45% |
1.45% |
1.45% |
|
|
|
|
|
|
Non - encumbered |
|
|
|
|
- Number of
Shares |
14601535 |
14592162 |
14601535 |
|
- Percentage
of Shares (as a % of
the total shareholding of promoter and promoter group) |
97.14% |
97.14% |
97.14% |
|
- Percentage
of Shares (as a % of
the total share capital of the company) |
49.23% |
49.19% |
49.23% |
|
|
PARTICULARS |
Quarter Ended 31.12.2014 |
|
B |
Investor
complaints (Nos.) |
|
|
|
Pending at the beginning of the quarter |
Nil |
|
|
Received during the quarter |
5 |
|
|
Disposed of during the quarter |
5 |
|
|
Remaining unresolved at the end of the quarter |
Nil |
SEGMENT REVENUE,
RESULTS AND CAPITAL EMPLOYED
(RS. IN MILLION)
|
PARTICULARS |
Quarter Ended |
Nine Months
Ended |
|
|
|
31.12.2014 [Unaudited] |
30.09.2014 [Unaudited] |
31.12.2014 [Unaudited] |
|
1. Segment Revenue |
|
|
|
|
a. Life Science Chemicals |
1683.800 |
1790.300 |
5247.000 |
|
b. Performance and Other Chemicals
|
4968.800 |
5198.800 |
15136.600 |
|
Total |
652.600 |
6989.100 |
20383.600 |
|
Less: Inter – segment revenue |
480.800 |
476.700 |
1337.500 |
|
Total income from operations (net) |
6171.800 |
6512.400 |
19046.100 |
|
|
|
|
|
|
2. Segment Results |
|
|
|
|
Profit/ (loss) before tax and interest |
|
|
|
|
a. Life Science Chemicals |
280.700 |
297.100 |
949.600 |
|
b. Performance and Other Chemicals
|
594.300 |
649.100 |
1848.600 |
|
Total |
875.000 |
946.200 |
2798.200 |
|
Less: Finance Costs |
62.500 |
57.300 |
181.500 |
|
Other un-allocable expenditure net off
un-allocable other operating income |
32.800 |
27.600 |
119.500 |
|
Total Profit Before Tax |
779.700 |
861.300 |
2497.200 |
|
|
|
|
|
|
3. Capital Employed |
|
|
|
|
(Segment Assets – Segment Liabilities) |
|
|
|
|
a. Life Science Chemicals |
3465.900 |
3314.100 |
3465.900 |
|
b. Performance and Other Chemicals
|
7503.700 |
7014.100 |
7503.700 |
|
c. Unallocated |
1890.300 |
2297.700 |
1890.300 |
|
Total |
12859.900 |
12625.900 |
12859.900 |
NOTE :
1. The above results have been reviewed and recommended for adoption by the Audit Committee at its meeting held on January 22, 2015 and approved by the Board of Directors at its meeting held on January 23, 2015.
2. The Board of Directors ("The Board") approved the Draft scheme of merger ("The scheme") of Amal Ltd with the Company on December 05, 2014. The Board has approved a share swap ratio of 1 equity share of the face value of Rs. 10 each fully paid up of Atul Ltd for every 50 equity shares of the face value of Rs. 10 each fully paid up of Amal Ltd. The scheme shall be subject to appropriate statutory and regulatory approvals. Pending such approvals, effect of the scheme is not given in the above results.
3. 'Other income' for the quarter / nine months ended December 31, 2013 included a one time special dividend of Rs. 198.600 Million.
4. The Company had reversed the revaluation reserve of Rs. 1013.800 Million, during the quarter / half year ended September 30, 2014.
5. Figures of the earlier periods have been regrouped / recast / reclassified wherever necessary including in the Segment revenue, results and capital employed.
6. The Auditors of the Company have carried out a Limited Review of the above financial results and their report contains no qualification.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 62.59 |
|
|
1 |
Rs. 92.46 |
|
Euro |
1 |
Rs. 67.51 |
INFORMATION DETAILS
|
Information gathered
by : |
SVA |
|
|
|
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
SNT |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
7 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
7 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
YES |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
YES |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
63 |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.